Lynda Charters

Quiescence, steroid-free quiescence achieved in VISUAL III trial

Intravitreal triamcinolone acetonide, dexamethasone implant superior for regional treatment of disorder

In patients with age-related macular degeneration managed by a treat-and-extend regimen, the visual acuity generally was maintained; lesion reactivation occurred frequently at about eight weeks; and longer induction phases between treatments was associated with worse outcomes.

Quantitative assessment of retinovascular features on ultra-widefield angiography images showed significant improvements in leakage and ischemia following treatment with aflibercept in patients with diabetic macular edema and retinal vein occlusion.

The metastatic prognosis does not increase when vitrectomy is performed at the time of brachytherapy.